SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-037338
Filing Date
2019-08-02
Accepted
2019-08-02 09:30:00
Documents
3
Period of Report
2019-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526619_8k.htm 8-K 23118
2 EXHIBIT 4.1 tv526619_ex4-1.htm EX-4.1 93508
3 EXHIBIT 10.1 tv526619_ex10-1.htm EX-10.1 52965
  Complete submission text file 0001144204-19-037338.txt   171132
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 19994608
SIC: 2836 Biological Products, (No Diagnostic Substances)